Related Experiment Video
Updated: Jul 29, 2025

Assay for Adhesion and Agar Invasion in S. cerevisiae
Published on: November 8, 2006
Human gasdermin D and MLKL disrupt mitochondria, endocytic traffic and TORC1 signalling in budding yeast
Marta Valenti1, María Molina1, Víctor J Cid1
1Departamento de Microbiología y Parasitología, Facultad de Farmacia, and Instituto Ramón y Cajal de Investigaciones Sanitarias (IRYCIS), Universidad Complutense de Madrid, Madrid 28040, Spain.
Abstract:
Gasdermin D (GSDMD) and mixed lineage kinase domain-like protein (MLKL) are the pore-forming effectors of pyroptosis and necroptosis, respectively, with the capacity to disturb plasma membrane selective permeability and induce regulated cell death. The budding yeast Saccharomyces cerevisiae has long been used as a simple eukaryotic model for the study of proteins associated with human diseases by heterologous expression. In this work, we expressed in yeast both GSDMD and its N-terminal domain (GSDMD(NT)) to characterize their cellular effects and compare them to those of MLKL. GSDMD(NT) and MLKL inhibited yeast growth, formed cytoplasmic aggregates and fragmented mitochondria. Loss-of-function point mutants of GSDMD(NT) showed affinity for this organelle. Besides, GSDMD(NT) and MLKL caused an irreversible cell cycle arrest through TORC1 inhibition and disrupted endosomal and autophagic vesicular traffic. Our results provide a basis for a humanized yeast platform to study GSDMD and MLKL, a useful tool for structure-function assays and drug discovery.
Insights
Gasdermin D (GSDMD) and mixed lineage kinase domain-like protein (MLKL) disrupt yeast cell functions, including growth and organelle integrity. This study establishes a humanized yeast model for studying these cell death proteins and aiding drug discovery.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Gasdermin D (GSDMD) and mixed lineage kinase domain-like protein (MLKL) are key effectors in pyroptosis and necroptosis, respectively.
- These proteins induce regulated cell death by disrupting plasma membrane integrity.
- Budding yeast (Saccharomyces cerevisiae) serves as a model eukaryote for studying human disease-associated proteins via heterologous expression.
Purpose of the Study:
- To characterize the cellular effects of GSDMD and its N-terminal domain (GSDMD(NT)) in yeast.
- To compare the effects of GSDMD(NT) with those of MLKL in the same model system.
- To establish a humanized yeast platform for studying GSDMD and MLKL functions and for drug discovery.
Main Methods:
- Heterologous expression of GSDMD, GSDMD(NT), and MLKL in Saccharomyces cerevisiae.
- Analysis of cellular effects including growth inhibition, aggregate formation, mitochondrial morphology, and cell cycle progression.
- Investigation of TORC1 signaling pathway and vesicular trafficking (endosomal and autophagic).
Main Results:
- Both GSDMD(NT) and MLKL inhibited yeast growth and formed cytoplasmic aggregates.
- Mitochondrial fragmentation was observed, with loss-of-function GSDMD(NT) mutants showing organelle affinity.
- Irreversible cell cycle arrest occurred via TORC1 inhibition, and both proteins disrupted vesicular traffic.
Conclusions:
- GSDMD and MLKL induce significant cellular perturbations in yeast, mirroring aspects of their function in mammalian cells.
- The study validates a humanized yeast model for investigating GSDMD and MLKL.
- This platform is suitable for structure-function analyses and the screening of potential therapeutic compounds.
More Related Videos
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
Yeast Signaling
Destabilization of Microtubules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

